32° Snow

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
- Local News
- State News
Sports
- Local Sports
- Pro Sports
Lifestyle
- Local Entertainment
Multimedia
Community Choice
Features
Classifieds
- Place Ad
- Legal Notices
Public Notices
Obituaries
E-Edition
STOCKING STUFFER CONTEST

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

9 Meters Biopharma, Inc. - Common Stock (NQ:NMTR)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 25, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about 9 Meters Biopharma, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

9 Meters Biopharma to Present at the Oppenheimer 33rd Annual Healthcare Conference

March 07, 2023

Via ACCESSWIRE

Benzinga's Top Ratings Upgrades, Downgrades For February 13, 2023 ↗

February 13, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 06, 2023

Via Benzinga

9 Meters Biopharma to Present at the 2023 BIO CEO & Investor Conference

January 31, 2023

Via ACCESSWIRE

Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 05, 2023

Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization...

Via Benzinga

9 Meters Biopharma Announces Phase 3 Study of Vurolenatide in Short Bowel Syndrome

November 29, 2022

Via ACCESSWIRE

Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session ↗

December 30, 2022

Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the...

Via Benzinga

9 Meters Biopharma Announces Continued Immuno-Oncology Collaboration with Gustave Roussy

November 14, 2022

Via ACCESSWIRE

9 Meters Biopharma Provides Business Update and Reports Financial Results for Third Quarter 2022

November 08, 2022

Via ACCESSWIRE

9 Meters Biopharma Presents Preclinical Data on Glucose-Dependent Insulinotropic Polypeptide (GIP) Monoclonal Antibodies for Obesity at the American College of Gastroenterology 2022 Annual Scientific Meeting

October 24, 2022

Via ACCESSWIRE

Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday ↗

October 24, 2022

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 21, 2022

Gainers

Via Benzinga

Why Boston Beer Shares Are Trading Higher? Here Are 52 Stocks Moving In Friday's Mid-Day Session ↗

October 21, 2022

Gainers Altamira Therapeutics Ltd. (NASDAQ: CYTO) surged 67% to $0.5484 after the company announced divestiture of its inner ear development assets.

Via Benzinga

Why Quoin Pharmaceuticals Shares Jumped By More Than 44%; Here Are 57 Biggest Movers From Yesterday ↗

October 19, 2022

Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares jumped 170.1% to close at $0.1194 on Tuesday after gaining 4% on Monday.

Via Benzinga

Why Akouos Shares Are Trading Sharply Higher? Here Are 36 Stocks Moving In Tuesday's Mid-Day Session ↗

October 18, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

October 18, 2022

During Tuesday's session, 78 companies made new 52-week lows.

Via Benzinga

9 Meters Biopharma to Present at the American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting

October 18, 2022

Via ACCESSWIRE

Why 9 Meters Biopharma Shares Are Nosediving Today ↗

October 17, 2022

9 Meters Biopharma Inc (NASDAQ: NMTR) shares are trading lower by 13.1% to $0.18 Monday morning after the company announced a 1-for-20 reverse stock split. What Else?

Via Benzinga

9 Meters Biopharma Announces 1-for-20 Reverse Stock Split

October 17, 2022

Via ACCESSWIRE

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

September 28, 2022

It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning.

Via InvestorPlace

Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket ↗

September 28, 2022

Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 27, 2022

Gainers

Via Benzinga

This Analyst Boosts PT On PepsiCo? Plus UBS Sees $75 For Micron Technology ↗

September 27, 2022

Deutsche Bank raised the price target on PepsiCo, Inc. (NASDAQ: PEP) from $179 to $181. Deutsche Bank analyst Steve Powers maintained a Hold rating on the stock. PepsiCo shares fell 1.2% to $166.47 on...

Via Benzinga

Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session ↗

September 27, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 27, 2022

Gainers 9 Meters Biopharma (NASDAQ:NMTR) stock moved upwards by 22.8% to $0.25 during Tuesday's pre-market session. The company's market cap stands at $65.8 million.

Via Benzinga

9 Meters Biopharma Shares Move Higher After Successful Short Bowel Syndrome Study ↗

September 27, 2022

9 Meters Biopharma Inc (NASDAQ: NMTR) announced the final results from the Phase 2 VIBRANT study of vurolenatide in short bowel syndrome (SBS) and the outcome of its End-of-Phase 2 meeting with the...

Via Benzinga

Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket ↗

September 27, 2022

Gainers 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for...

Via Benzinga

9 Meters Biopharma Announces Positive Final Results from Phase 2 VIBRANT Study and Successful End-of-Phase 2 Meeting with FDA for Vurolenatide in Short Bowel Syndrome

September 26, 2022

Via ACCESSWIRE

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 16, 2022

Via Benzinga

9 Meters Biopharma to Present at the H.C. Wainwright 24th Annual Global Investment Conference

September 06, 2022

Via ACCESSWIRE

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Multimedia
Local Events
Classifieds
Obituaries
Weather
Online Features

Services

About Us
Contact Us
Promote Your Event
Subscriber Services
Online Forms
Rack Locations

woonsocketcall.com
Address: 154 Main Street
Woonsocket, RI 02895
Phone: 401-762-3000
Email: notices@woonsocketcall.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

9 Meters Biopharma, Inc. - Common Stock (NQ:NMTR)

All News about 9 Meters Biopharma, Inc. - Common Stock

Sections

Services